312 related articles for article (PubMed ID: 19221469)
1. Inactivation of RASSF1A, RARbeta2 and DAP-kinase by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma.
Fendri A; Masmoudi A; Khabir A; Sellami-Boudawara T; Daoud J; Frikha M; Ghorbel A; Gargouri A; Mokdad-Gargouri R
Cancer Biol Ther; 2009 Mar; 8(5):444-51. PubMed ID: 19221469
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma.
Kwong J; Lo KW; To KF; Teo PM; Johnson PJ; Huang DP
Clin Cancer Res; 2002 Jan; 8(1):131-7. PubMed ID: 11801549
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of DAPK and RASSF1A promoter hypermethylation in non-small cell lung cancer (NSCLC).
Niklinska W; Naumnik W; Sulewska A; Kozłowski M; Pankiewicz W; Milewski R
Folia Histochem Cytobiol; 2009; 47(2):275-80. PubMed ID: 19926549
[TBL] [Abstract][Full Text] [Related]
4. Effect of methylation-associated silencing of the death-associated protein kinase gene on nasopharyngeal carcinoma.
Kong WJ; Zhang S; Guo CK; Wang YJ; Chen X; Zhang SL; Zhang D; Liu Z; Kong W
Anticancer Drugs; 2006 Mar; 17(3):251-9. PubMed ID: 16520653
[TBL] [Abstract][Full Text] [Related]
5. Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Lee ES; Issa JP; Roberts DB; Williams MD; Weber RS; Kies MS; El-Naggar AK
Clin Cancer Res; 2008 May; 14(9):2664-72. PubMed ID: 18451230
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of RARβ2 correlates with high COX-2 expression and poor prognosis in patients with colorectal carcinoma.
Miladi-Abdennadher I; Abdelmaksoud-Damak R; Ayadi L; Khabir A; Frikha F; Kallel L; Amouri A; Frikha M; Sellami-Boudawara T; Gargouri A; Mokdad-Gargouri R
Tumour Biol; 2010 Oct; 31(5):503-11. PubMed ID: 20571967
[TBL] [Abstract][Full Text] [Related]
7. Detection of breast cancer in nipple aspirate fluid by CpG island hypermethylation.
Krassenstein R; Sauter E; Dulaimi E; Battagli C; Ehya H; Klein-Szanto A; Cairns P
Clin Cancer Res; 2004 Jan; 10(1 Pt 1):28-32. PubMed ID: 14734448
[TBL] [Abstract][Full Text] [Related]
8. Methylation associated inactivation of RASSF1A and its synergistic effect with activated K-Ras in nasopharyngeal carcinoma.
Wang T; Liu H; Chen Y; Liu W; Yu J; Wu G
J Exp Clin Cancer Res; 2009 Dec; 28(1):160. PubMed ID: 20042089
[TBL] [Abstract][Full Text] [Related]
9. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
10. Promoter hypermethylation of DAP-kinase is associated with poor survival in primary biliary tract carcinoma patients.
Tozawa T; Tamura G; Honda T; Nawata S; Kimura W; Makino N; Kawata S; Sugai T; Suto T; Motoyama T
Cancer Sci; 2004 Sep; 95(9):736-40. PubMed ID: 15471559
[TBL] [Abstract][Full Text] [Related]
11. Promoter methylation of RASSF1A and DAPK and mutations of K-ras, p53, and EGFR in lung tumors from smokers and never-smokers.
Liu Y; Gao W; Siegfried JM; Weissfeld JL; Luketich JD; Keohavong P
BMC Cancer; 2007 May; 7():74. PubMed ID: 17477876
[TBL] [Abstract][Full Text] [Related]
12. Silencing of the retinoid response gene TIG1 by promoter hypermethylation in nasopharyngeal carcinoma.
Kwong J; Lo KW; Chow LS; Chan FL; To KF; Huang DP
Int J Cancer; 2005 Jan; 113(3):386-92. PubMed ID: 15455391
[TBL] [Abstract][Full Text] [Related]
13. Patterns of aberrant DNA hypermethylation in nasopharyngeal carcinoma in Tunisian patients.
Challouf S; Ziadi S; Zaghdoudi R; Ksiaa F; Ben Gacem R; Trimeche M
Clin Chim Acta; 2012 Apr; 413(7-8):795-802. PubMed ID: 22296674
[TBL] [Abstract][Full Text] [Related]
14. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.
Van der Auwera I; Bovie C; Svensson C; Limame R; Trinh XB; van Dam P; Van Laere SJ; Van Marck E; Vermeulen PB; Dirix LY
Cancer Biol Ther; 2009 Dec; 8(23):2252-9. PubMed ID: 19829046
[TBL] [Abstract][Full Text] [Related]
15. High frequency of promoter hypermethylation of the death-associated protein-kinase gene in nasopharyngeal carcinoma and its detection in the peripheral blood of patients.
Wong TS; Chang HW; Tang KC; Wei WI; Kwong DL; Sham JS; Yuen AP; Kwong YL
Clin Cancer Res; 2002 Feb; 8(2):433-7. PubMed ID: 11839660
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
17. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions.
Zou XP; Zhang B; Zhang XQ; Chen M; Cao J; Liu WJ
Hum Pathol; 2009 Nov; 40(11):1534-42. PubMed ID: 19695681
[TBL] [Abstract][Full Text] [Related]
18. Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients.
Karray-Chouayekh S; Trifa F; Khabir A; Boujelbane N; Sellami-Boudawara T; Daoud J; Frikha M; Jlidi R; Gargouri A; Mokdad-Gargouri R
J Cancer Res Clin Oncol; 2010 Feb; 136(2):203-10. PubMed ID: 19657672
[TBL] [Abstract][Full Text] [Related]
19. High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma.
Lo KW; Kwong J; Hui AB; Chan SY; To KF; Chan AS; Chow LS; Teo PM; Johnson PJ; Huang DP
Cancer Res; 2001 May; 61(10):3877-81. PubMed ID: 11358799
[TBL] [Abstract][Full Text] [Related]
20. Clinical significance of promoter hypermethylation of RASSF1A, RARbeta2, BRCA1 and HOXA5 in breast cancers of Indian patients.
Bagadi SA; Prasad CP; Kaur J; Srivastava A; Prashad R; Gupta SD; Ralhan R
Life Sci; 2008 Jun; 82(25-26):1288-92. PubMed ID: 18538349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
